Ontario Funds High Impact Clinical Trials with $12.7M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research has been awarded C$12.6 million (US$12.7 million) from the provincial government to fund a clinical trials program that will use genomics and personalized medicine in a translational science effort, OICR said Monday.

The funding will be used to support two trials that are part of the High Impact Clinical Trials (HICT) Program over a four-year period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.